Bio Essence Corp. is a herbal health, diet, and nutrition company. The Company is mainly engaged in selling health supplements and providing original equipment manufacturing (OEM) services. The Company also outsources manufacturing / OEM services.

Employees

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
26-10-23	US$0.4201	-.--%	10,670

Real-time OTC Markets

More quotes

Real-time OTC Markets 13:00:15 2026-05-15 EDT			5-day change	1st Jan Change
0.3800 ^USD	-.--%		-9.55%	+533.33%

10-23	Bio Essence Corp. Announces Board Changes, Effective October 19, 2026	CI
08-14	Bio Essence Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

Market Cap	22.61M 20.29M 18.73M 16.99M 31.75M 2.15B 32.14M 225M 89.2M 1.13B 84.85M 83.04M 3.57B	P/E 2024	-7x	P/E 2025	2.54x
Enterprise Value	24.17M 21.69M 20.03M 18.16M 33.95M 2.3B 34.36M 240M 95.37M 1.2B 90.72M 88.78M 3.82B	EV / Sales 2024	36.6x	EV / Sales 2025	2.03x
Free-Float	36.08%	Yield 2024 *	-	Yield 2025	-

10-23	Bio Essence Corp. Announces Board Changes, Effective October 19, 2026	CI
08-14	Bio Essence Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-18	Bio Essence Corporation completed the acquisition of MediFlow AI from Zhituo Software Co., Limited.	CI
05-15	Bio Essence Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
04-24	Bio Essence Corporation has entered into a Asset Purchase Agreement to acquire MediFlow AI from Zhituo Software Co., Limited for $3.1 million.	CI
03-27	Bio Essence Corporation Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-26	Bio Essence Corporation Auditor Raises 'Going Concern' Doubt	CI
11-12	Bio Essence Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
25-08-14	Bio Essence Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
25-05-15	Bio Essence Corporation Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
25-03-28	Bio Essence Corporation Reports Earnings Results for the Full Year Ended December 31, 2024	CI
25-03-27	Bio Essence Corporation Auditor Raises 'Going Concern' Doubt	CI
24-11-14	Bio Essence Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI

11-12	Bio Essence : Quarterly Report for Quarter Ending September 30, 2025 (Form 10-Q)	PU
24-10-07	Bio Essence : Amendment to Quarterly Report Form 10 Q/A	PU
24-10-07	Bio Essence : Non Reliance of Financial Report Form 8 K	PU
23-03-30	BIO ESSENCE CORP Management's Discussion and Analysis of Financial Condition and Results of Operation. (form 10-K)	AQ
22-05-16	BIO ESSENCE CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	AQ

Bio Essence Corporation Stock

Stocks

BIOE

US09090C1053

Pharmaceuticals

Valuation: Bio Essence Corporation

Chart: Bio Essence Corporation

Latest news: Bio Essence Corporation

Press Releases: Bio Essence Corporation

Quotes and Performance

Price Extremes

Managers and Directors: Bio Essence Corporation

Latest insider transactions

Other Pharmaceuticals

Financials

Company Profile

Quotes

1 week	-9.55%
Current month	+108.91%
1 month	+108.91%
3 months	+40.58%
6 months	-15.56%
Current year	+533.33%

1 week	0.38	0.43
1 month	0.19	0.43
Current year	0.05	0.52
1 year	0.05	0.52
3 years	0.05	10.81
5 years	0.05	10.81
10 years	0.05	10.81

Manager	Title	Age	Since
Yin Yan CEO	Chief Executive Officer	50	-
Bill Sluss DFI	Director of Finance/CFO	71	2023-09-06
Tuan Tran COO	Chief Operating Officer	52	2017-12-31

Director	Title	Age	Since
Yin Yan CHM	Chairman	50	-
Siyavash Fooladian BRD	Director/Board Member	54	-
Bill Sluss BRD	Director/Board Member	71	2024-06-17

Date	Insider	Type	Main position	Quantity	% Market Cap.
10/28/24	Yin Yan	Sell	Chief Executive Officer	323,845	0.8520%
7/11/24	Yin Yan	Sell	Chief Executive Officer	92,190	0.2425%
7/2/24	Yin Yan	Sell	Chief Executive Officer	223,965	0.5892%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
BIO ESSENCE CORPORATION	-.--%	-9.55%	+453.13%	-25.49%	22.61M
ELI LILLY AND COMPANY	+0.85%	+1.40%	+57.12%	+127.78%	1,143B
JOHNSON & JOHNSON	+0.46%	+4.40%	+43.96%	+83.03%	647B
ABBVIE INC.	+0.11%	+0.23%	+25.45%	+101.18%	506B
ROCHE HOLDING AG	+0.19%	+1.73%	+52.74%	+65.27%	384B
MERCK & CO., INC.	-0.09%	-5.31%	+63.07%	+38.22%	350B
NOVARTIS AG	+1.25%	+2.54%	+31.59%	+53.73%	293B
ASTRAZENECA PLC	+0.45%	+1.74%	+3.45%	+25.60%	265B
AMGEN INC.	+0.82%	+2.71%	+54.13%	+71.06%	242B
GILEAD SCIENCES, INC.	+0.56%	+3.62%	+34.99%	+104.61%	197B
Average	+0.50%	+0.76%	+81.96%	+64.50%	402.76B
Weighted average by Cap.	+0.58%	+0.71%	+44.48%	+86.85%

	2024	2025
Net sales	324K 291K 268K 243K 455K 30.77M 461K 3.22M 1.28M 16.13M 1.22M 1.19M 51.14M	1.9M 1.7M 1.57M 1.43M 2.67M 180M 2.7M 18.85M 7.49M 94.47M 7.12M 6.97M 300M
Net income	-1.31M -1.17M -1.08M -984K -1.84M -124M -1.86M -13M -5.16M -65.16M -4.91M -4.81M -207M	896K 804K 743K 673K 1.26M 85.13M 1.27M 8.9M 3.54M 44.62M 3.36M 3.29M 141M
Net Debt	2.7M 2.43M 2.24M 2.03M 3.8M 257M 3.84M 26.86M 10.67M 135M 10.15M 9.93M 427M	1.56M 1.4M 1.3M 1.17M 2.2M 148M 2.22M 15.53M 6.17M 77.82M 5.87M 5.74M 247M